IPG515 |
Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section
|
Interventional procedure guidance
|
Intrapartum care
|
IPG517 |
Insertion of endobronchial nitinol coils to improve lung function in emphysema
|
Interventional procedure guidance
|
Chronic obstructive pulmonary disease
|
QS84 |
Physical activity: encouraging activity in all people in contact with the NHS
|
Quality standards
|
Physical activity
|
TA337 |
Rifaximin for preventing episodes of overt hepatic encephalopathy
|
Technology appraisal guidance
|
Liver conditions: general and other
|
QS85 |
Managing medicines in care homes
|
Quality standards
|
Medicines management: general and other
|
TA336 |
Empagliflozin in combination therapy for treating type 2 diabetes
|
Technology appraisal guidance
|
Diabetes
|
QS82 |
Smoking: reducing tobacco use
|
Quality standards
|
Smoking and tobacco
|
QS86 |
Falls in older people: assessment after a fall and preventing further falls
|
Quality standards
|
Injuries, accidents and wounds: general and other
|
TA338 |
Pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
|
Technology appraisal guidance
|
Blood and bone marrow cancers
|
QS83 |
Alcohol: preventing harmful alcohol use in the community
|
Quality standards
|
Communities
|
IPG514 |
Transanal total mesorectal excision of the rectum
|
Interventional procedure guidance
|
Colorectal cancer
|
IPG516 |
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation
|
Interventional procedure guidance
|
Cardiovascular conditions: general and other
|
IPG518 |
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
|
Interventional procedure guidance
|
Diabetes
|
MTG24 |
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters
|
Medical technology guidance
|
Surgical care
|
TA335 |
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
|
Technology appraisal guidance
|
Acute coronary syndromes
|
IPG512 |
Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis
|
Interventional procedure guidance
|
Knee conditions
|
NG7 |
Maintaining a healthy weight and preventing excess weight gain among adults and children
|
Guideline
|
Diet, nutrition and obesity
|
NG6 |
Excess winter deaths and morbidity and the health risks associated with cold homes
|
Guideline
|
Vulnerable groups
|
NG5 |
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
|
Guideline
|
Medicines management: general and other
|
CG28 |
Depression in children and young people: Identification and management in primary, community and secondary care
|
Clinical guidelines
|
Children and young people
|
No hay comentarios:
Publicar un comentario